{"id":992665,"date":"2026-08-10T08:12:37","date_gmt":"2026-08-10T12:12:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/"},"modified":"2026-08-10T08:12:37","modified_gmt":"2026-08-10T12:12:37","slug":"rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/","title":{"rendered":"Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        \n      <\/p>\n<p align=\"justify\">SAN JOSE, Calif., Aug.  10, 2026  (GLOBE NEWSWIRE) &#8212; Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company\u2019s management team will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference. Details below:<\/p>\n<p align=\"justify\">\n        <strong>Canaccord Genuity 46th Annual Growth Conference<\/strong><br \/>\n        <br \/>\n        <strong>Date:<\/strong> Wednesday, August 12, 2026 at 2:30pm E.T.<br \/><strong>Location:<\/strong> Boston, MA<br \/><strong>Presenter:<\/strong> Chief Executive Officer, Talat Imran, and Chief Financial Officer, Nicholas Maestas<br \/><strong>Format:<\/strong> Presentation and 1&#215;1 Meetings<\/p>\n<p align=\"justify\">Interested parties can access the live webcast for this conference from the Investor Relations section of the company&#8217;s website at www.ranitherapeutics.com. The webcast replay will be available after the conclusion of the presentation.<\/p>\n<p>\n        <strong>About Rani Therapeutics<\/strong>\n      <\/p>\n<p align=\"justify\">Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill<sup>\u00ae<\/sup> Capsule, a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill<sup>\u00ae<\/sup> Capsule technology.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7R7QG9YLBW662a5WFoTGmJTDq5VJzrQE1M7kL654Ho5IimSk9kZV_rR-nB9yRod5iW456Bi962Z19PXjsAMCGy_zZ6a8Ns7hueqSv3GvC3BC04olXNxGmXeJpumFBJ9jv03tdKhujx1edAHJQskEp2nmIWPfqLKAKflRZZJacT-HgCIDd7klzu-122GeWp1uxiu4rohfi6SiOPpd_mrNG_ClmN6RCt-QGSQw-OjkfKJMJ0zjctpR3TrmHbsEUYt9funWduVbntXmHboMMVO5WgefbpTx2__UPx1CSxX3qKdxa7EpegQcv_aSAOOChMs9\" rel=\"nofollow\" target=\"_blank\">investors@ranitherapeutics.com<\/a>\u00a0\u00a0<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Wngsw9jbpXfjxlsbzl59z5YQJ-o3z6_XC6ny8vY-SpgSP20zNN9x2UUSDvt2Dr3vBf5mHutlDTszP2yfrF_hr8rweg67ZsdVhhTYWbBCkJ8558og5fz_m26cqXrALcn73tlK3AbWW5oU0wjVm2Z8EKnCWMYlLqI1g34tlYfDsF-W7NGnBB2o5wLS83HtjLEixlt8oOwPQGBImtvGoTUVT9jlWql3hoAhtGjJ41SdpXd9-aR8EmJF7gvO3emGpHeh8cGBypcPOoJw8qctkMszZPXa8LvjeWEHaZyhUQ2WOSo=\" rel=\"nofollow\" target=\"_blank\">media@ranitherapeutics.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNjI4NCM3NzY2MDIxIzIyMDg2OTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjgxMTZjYTktOWZiNi00OTJiLTk1MWEtZWZlMTE2ZGQ5OGE2LTEyMjAyNTItMjAyNi0wOC0xMC1lbg==\/tiny\/Rani-Therapeutics-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) &#8212; Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company\u2019s management team will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference. Details below: Canaccord Genuity 46th Annual Growth Conference Date: Wednesday, August 12, 2026 at 2:30pm E.T.Location: Boston, MAPresenter: Chief Executive Officer, Talat Imran, and Chief Financial Officer, Nicholas MaestasFormat: Presentation and 1&#215;1 Meetings Interested parties can access the live webcast for this conference from the Investor Relations section of the company&#8217;s website at www.ranitherapeutics.com. The webcast replay will be available after the conclusion of the presentation. About Rani Therapeutics Rani Therapeutics is a clinical-stage biotherapeutics company focused &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-992665","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) &#8212; Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company\u2019s management team will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference. Details below: Canaccord Genuity 46th Annual Growth Conference Date: Wednesday, August 12, 2026 at 2:30pm E.T.Location: Boston, MAPresenter: Chief Executive Officer, Talat Imran, and Chief Financial Officer, Nicholas MaestasFormat: Presentation and 1&#215;1 Meetings Interested parties can access the live webcast for this conference from the Investor Relations section of the company&#8217;s website at www.ranitherapeutics.com. The webcast replay will be available after the conclusion of the presentation. About Rani Therapeutics Rani Therapeutics is a clinical-stage biotherapeutics company focused &hellip; Continue reading &quot;Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-10T12:12:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNjI4NCM3NzY2MDIxIzIyMDg2OTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference\",\"datePublished\":\"2026-08-10T12:12:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/\"},\"wordCount\":205,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNjI4NCM3NzY2MDIxIzIyMDg2OTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/\",\"name\":\"Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNjI4NCM3NzY2MDIxIzIyMDg2OTk=\",\"datePublished\":\"2026-08-10T12:12:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNjI4NCM3NzY2MDIxIzIyMDg2OTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNjI4NCM3NzY2MDIxIzIyMDg2OTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/","og_locale":"en_US","og_type":"article","og_title":"Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk","og_description":"SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) &#8212; Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company\u2019s management team will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference. Details below: Canaccord Genuity 46th Annual Growth Conference Date: Wednesday, August 12, 2026 at 2:30pm E.T.Location: Boston, MAPresenter: Chief Executive Officer, Talat Imran, and Chief Financial Officer, Nicholas MaestasFormat: Presentation and 1&#215;1 Meetings Interested parties can access the live webcast for this conference from the Investor Relations section of the company&#8217;s website at www.ranitherapeutics.com. The webcast replay will be available after the conclusion of the presentation. About Rani Therapeutics Rani Therapeutics is a clinical-stage biotherapeutics company focused &hellip; Continue reading \"Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-10T12:12:37+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNjI4NCM3NzY2MDIxIzIyMDg2OTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference","datePublished":"2026-08-10T12:12:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/"},"wordCount":205,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNjI4NCM3NzY2MDIxIzIyMDg2OTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/","name":"Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNjI4NCM3NzY2MDIxIzIyMDg2OTk=","datePublished":"2026-08-10T12:12:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNjI4NCM3NzY2MDIxIzIyMDg2OTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNjI4NCM3NzY2MDIxIzIyMDg2OTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/992665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=992665"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/992665\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=992665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=992665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=992665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}